WHO Chief Scientist issued legal notice in India allegedly suppressed data on drugs to treat COVID-19

The Indian Bar Association has taken legal action on suspicion that Dr. Soumya Swaminathan, a World Health Organization (WHO) chief scientist, was involved in the disinformation disinformation about the use of ivermectin in the treatment of COVID-19. ..

The association has served a legal notice (pdf) At Swaminasan on May 25, she argued that she was “spreading disinformation and misleading the Indian people in order to serve her purpose” and tried to prevent “causing further damage”. ..

In addition, Swaminasan said in a statement against the use of ivermectin that he ignored studies and clinical trials from two organizations, the Frontline COVID-19 Critical Care (FLCCC) Alliance and the UK Ivermectin Recommendation Development (BIRD). .. Data showing that ivermectin prevents and treats COVID-19.

“Dr. Soumya Swaminathan deliberately concealed data on the efficacy of the drug ivermectin in an attempt to disregard these studies / reports and discourage Indians from using ivermectin,” the plaintiff said in a statement. Stated in (pdf).

In a May 10 tweet that was deleted after the notice was issued, Swaminasan said: I have written“Safety and efficacy are important when using drugs for new indications. WHO recommends opposition to the use of ivermectin for COVID-19 outside of clinical trials.”

Swaminasan posted on Twitter shortly after Gore’s Minister of Health Announced Give ivermectin as a preventative measure to all Goa residents over the age of 18 as part of the state government’s efforts to stop the transmission of the virus, regardless of COVID-19 status. India from March 2021 The CCP (Communist Party of China) virus has been hit hard by the second wave of the pandemic.

The legal notice calls for a clear response from Swaminatan on many important points, and the Association has the right to initiate a prosecution under the Indian Criminal Law and Disasters section if it does not provide a clear response. Management Act stated to be reserved, 2005.

WHO Chief Scientist did not respond to requests for comment.

The Epoch Times
As part of the Center’s research, healthcare professionals have received a bottle of ivermectin, a drug approved by the National Institute of Food and Drug Monitoring (INVIMA) to treat patients with mild, asymptomatic, or suspected COVID-19. Shows the box that contains it. Childhood Infectious Diseases Study in Cali, Colombia, July 21, 2020 (Luis Robayo / AFP via Getty Images)

A link to Merck’s statement about ivermectin was also included in Swaminasan’s tweet. A pharmaceutical company that developed anthelmintic drugs in the 1980s and obtained patents until 1996. Said In February of this year, the data available did not support the efficacy and safety of ivermectin beyond what was approved by the Food and Drug Administration (FDA).

Merck is working with Ridgeback Biotherapeutics to conduct a phase 3 trial of the antiviral drug molnupiravir. The company states that it has been shown to reduce infectious viruses in COVID-19 outpatients more quickly. However, unlike ivermectin, molnupiravir had no clinical effect on inpatients.

The exam is scheduled to be completed in late October this year, Merck Said If the results are good, apply for an emergency licensed use of the drug.

Researchers hope that molnupiravir impairs the ability to replicate the CCP virus, preventing serious illness and hospitalization. ivmmeta.com, A website that provides a real-time meta-analysis of ivermectin research.

Twenty-three early-treatment studies showed a 78% improvement in patients receiving ivermectin, and 14 prophylaxis studies showed an 85% improvement. For studies involving late-stage treatment, 20 studies showed a 45% improvement.

Proponents of ivermectin state that the drug can treat all stages of COVID-19 and its antiviral and anti-inflammatory properties can reduce hospitalization and mortality. However, US federal health authorities and WHO are opposed to approving the drug as a treatment for COVID-19.

FDA To tell It has not approved ivermectin for COVID-19, and in early March warned people not to take animal medications, as high doses to animals can be harmful to humans. Did.

The National Institutes of Health (NIH), the largest medical research institute, does not recommend or object to the use of ivermectin for the treatment of COVID-19. Updated guidelines During February. This happened after members of the FLCCC Alliance submitted data to the institution earlier this year.

NIH announced in April that it would fund a large randomized controlled trial of seven diversions to treat patients with mild to moderate COVID-19.The institute said it would begin enrolling in Phase 3 trial Ivermectin next month.

A NIH spokeswoman told The Epoch Times by email: “Exam registration is scheduled to begin this month and the exam will run for up to two years.

WHO advises in its living guidelines to oppose the use of ivermectin outside the clinical environment, citing non-conclusive data similar to both FDA and NIH.

“The current evidence of using ivermectin to treat patients with COVID-19 is not conclusive,” WHO said. Said In a press release. “Until more data are available, WHO recommends using this drug only in clinical trials.”

Dr. Pierre Kory, President and Chief Medical Officer of the FLCCC Alliance, claims that there is a collaborative effort to censor information on the efficacy of ivermectin against COVID-19, a disease caused by the CCP virus.

“There are forces trying to prevent ivermectin from being widely accepted as an effective treatment,” Collie said. Said In an interview on June 1st.

“We have randomized [trials], You have observing power [studies], Case series, epidemiological analysis, and clinical experience with physicians. The doctor who incorporated ivermectin into the treatment can’t come back and find a doctor who says my patient didn’t get better. I can’t find the doctor, “he added.

The Epoch Times
Screenshots of the results of a meta-analysis of 57 clinical trials on the use of ivermectin in COVID-19 patients from ivemmeta.com. (Screenshot of The Epoch Times)

Ivermectin has not yet been approved for the treatment of COVID-19, but doctors around the world, including the United States, are providing it to patients. And for doctors who refused to administer the drug to patients suffering from severe COVID-19, the judge had to order them to do so.

The Indian Bar Association cited the case of 80-year-old Judith Smentkywitz in a legal notice. He fully recovered after wearing the ventilator and said he had only a 20% chance of survival. Her family obtained a court order permitting her to receive additional doses of ivermectin after the doctor hesitated to take multiple doses of ivermectin. Buffalo News..

Smentkiewic’s family and lawyers say they believe that ivermectin saved her life.

Ivermectin is on the WHO Model List of Essentials and has a high safety profile with over 3.7 billion doses over 30 years.

According to Dr. Tess Laurie, since the drug was first administered to humans in 1987, only 4,600 adverse events and 16 deaths have been reported in the Pharmacovigilance database. interview Raleigh is the director of Evidence-based Medicine Consultancy Ltd. and co-founder of the BIRD Panel with the participation of international expert scientists and physicians advocating the use of ivermectin for the treatment of COVID-19. is.

The antiviral drug remdesivir is the only FDA-approved treatment to treat patients with COVID-19 in the hospital. The drug had no effect on mortality and showed only the slight benefit that even WHO had in recovery time. Recommended for Used in November last year.

According to Kory, the treatment course for remdesivir is just over $ 3,000, but the cost of ivermectin is $ 3-12 per treatment.

He also said that in places in India where ivermectin is used as a preventative or early treatment, such as Goa and Uttar Pradesh, there are fewer cases of COVID-19 than in states that ban the drug. ..

“In all of these states, the curve is now sharply declining,” says Kory.

“But India has a state called Tamil Nadu, whose minister basically outlawed ivermectin, threw all his energy into Remdesivir, and bought a lot of Remdesivir. [and] The number of cases and deaths in the state is skyrocketing, “he added.

The Epoch Times asked the Prime Minister of Tamil Nadu for comment.

According to data from the Johns Hopkins University Center for Systems Science and Engineering, Tamil Nadu confirmed 20,421 new cases and 434 deaths on June 6, and 403 new cases and 16 deaths in Goa. Deaths were recorded, with 1,037 cases and 85 deaths reported in Uttar Pradesh.

Uttar Pradesh, one of India’s most populous states with over 200 million people, distributes a free 7-day medical kit for COVID-19-positive patients in quarantine. One of them is ivermectin.